In vitro activity of commercial probiotic Lactobacillus strains against uropathogenic Escherichia coli

FEMS Microbiology Letters

Volumn 362, Issue 13, 2015, Pages

  Delley, Michèle ^a   Bruttin, Anne ^a   Richard, Michel ^a   Affolter, Michael ^a   Rezzonico, Enea ^a   Brück, Wolfram M ^a,b  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b UNIVERSITY OF APPLIED SCIENCES WESTERN SWITZERLAND   (Switzerland)

Author keywords

Bacterial coculture; Cell culture; Cell free culture supernatants; Lactobacillus spp.; UPEC; UTI

Indexed keywords

PROBIOTIC AGENT; LACTIC ACID; SUCCINIC ACID;

ACIDIFICATION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIOSTASIS; BACTERIUM ADHERENCE; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS JOHNSONII; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PRIORITY JOURNAL; UROPATHOGENIC ESCHERICHIA COLI; ANTIBIOSIS; CLASSIFICATION; FEMALE; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; LACTOBACILLUS; METABOLISM; MICROFLORA; PATHOGENICITY; PHYSIOLOGY; TUMOR CELL LINE; URINARY TRACT INFECTIONS;

ANTIBIOSIS; BACTERIAL ADHESION; CELL LINE, TUMOR; FEMALE; HUMANS; LACTIC ACID; LACTOBACILLUS; MICROBIOTA; PROBIOTICS; SUCCINIC ACID; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84948993375     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1093/femsle/fnv096     Document Type: Article

References (25)

1. Alakomi H, Skytta E, Saarela M, et al. Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl Environ Microb 2000;66:2001-5.
2. Ali ASM, Townes CL, Hall JL, et al. Maintaining a sterile urinary tract: the role of antimicrobial peptides. J Urol 2009;182:21-8.
3. Atassi F, Servin AL. Individual and co-operative roles of lactic acid and hydrogen peroxide in the killing activity of enteric strain Lactobacillus johnsonii NCC933 and vaginal strain Lactobacillus gasseri KS120.1 against enteric, uropathogenic and vaginosis-associated pathogens. FEMS Microbiol Lett 2010;304:29-38.
4. Blango MG, Mulvey MA. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Ch 2010;54:1855-63.
5. Bruce AW, Reid G. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can J Microbiol 1988;34:339-43.
6. Cadieux PA, Burton J, Devillard E, et al. Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol 2009;60 (Suppl 6):13-18.
7. De Keersmaecker SCJ, Verhoeven TLA, Desair J, et al. Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid. FEMS Microbiol Lett 2006;259:89-96.
8. Edwards AM, Massey RC. Invasion of human cells by a bacterial pathogen. J Vis Exp 2011;49:e2693.
9. Eto DS, Sundsbak JL, Mulvey MA. Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell Microbiol 2006;8:704-17.
10. Fayol-Messaoudi D, Berger CN, Coconnier-Polter MH, et al. pH-, lactic acid-, and non-lactic acid-dependent activities of probiotic lactobacilli against Salmonella enterica serovar typhimurium. Appl Environ Microb 2005;71:6008-13.
11. Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health 1990;80:331-3.
12. Guay DRP. Cranberry and urinary tract infections. Drugs 2009;69:775-807.
13. Hagan EC, Mobley HLT. Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun 2007;75:3941-9.
14. Kirjavainen PV, Laine RM, Carter DE, et al. Expression of antimicrobial defense factors in vaginal mucosa following exposure to Lactobacillus rhamnosus GR-1. Int J Probiotics Prebiotics 2008;3:99-106.
15. Kontiokari T, Laitinen J, Järvi L, et al. Dietary factors protecting women from urinary tract infection. Am J Clin Nutr 2003;77:600-04.
16. Liu HY, Roos S, Jonsson H, et al. Effects of Lactobacillus johnsonii and Lactobacillus reuteri on gut barrier function and heat shock proteins in intestinal porcine epithelial cells. Phys Rep 2015;3:e12355.
17. Makras L, Triantafyllou V, Fayol-Messaoudi D, et al. Kinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory compounds. Res Microbiol 2006;157:241-7.
18. Mobley H, Green D, Trifillis A, et al. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 1990;58:1281-9.
19. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 2001;69:4572-9.
20. Niku-Paavola ML, Laitila A, Mattila-Sandholm T, et al. New types of antimicrobial compounds produced by Lactobacillus plantarum. J Appl Microbiol 1999;86: 29-35.
21. Presser KA, Ratkowsky DA, Ross T. Modelling the growth rate of Escherichia coli as a function of pH and lactic acid concentration. Appl Environ Microb 1997;63:2355-60.
22. Reid G, Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 2002;4:319-24.
23. Saxelin M, Pessi T, Salminen S. Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. Int J Food Microbiol 1995;25:199-203.
24. Sivick KE, Mobley HLT. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 2010;78:568-85.
25. Velraeds MMC, van de Belt-Gritter B, van der Mei HC, et al. Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J Urol 1999;162:1573